AI Global Healthcare Initiative Logomark

AI Global Healthcare Initiative

AI in Operations Work Team

Moving to a world of predictive methodologies to protect and advance public health.

AIO Work Team Goal

The AI in Operations Team (AIO) is an organized, cross-industry discussion group of FDA officials and industry professionals working to increase the predictive assurance of product quality across all operations (e.g.., manufacturing, quality, supply chain, etc.) through the power of AI.

AIO Problem Statement

The medical device and pharmaceutical industries are anxious and hesitant to expand their use of artificial intelligence in operations. The saying “I want to be the first to be second” rings true in some cases, while others are forging ahead. The AI in Operations Team is collaboratively working to increase the awareness of how AI is already being used, and exploring additional applications.

AIO Work Team Deliverables

​In February of 2022, the efforts of Xavier Health were assumed by the AFDO/RAPS Healthcare Products Collaborative. Because of the important work done before this transition, the Collaborative has chosen to retain documents that have Xavier branding and continue to provide them to the communities through this website.  If you have questions, please contact us at info@healthcareproducts.org.

2021

AI Checklist Tool (Link)

2020

2019

Survey results that measure the current status of how AI is being used in manufacturing

2018

System Map demonstrating interconnectivity and potential causal relationships between GMP systems, non-GMP systems and the complaint system:

Summary of data elements that represent risks and/or potential failure modes for the events captured in the complaint system:

Definitions of AI relevant terms to harmonize understanding:

Team Leaders

George

Brunner

Chief Data Scientist

Acumen Analytics

George Brunner serves as Chief Data Scientist at Acumen Analytics, a Philadelphia-based technology solutions provider serving pharmaceutical, biotech, and manufacturing industries since 2004. The award-winning WBE company specializes in advanced analytics and data-driven transformation in life sciences, combining industry expertise with innovative technology solutions.

Lacey

Harbour

Regulatory Affairs Manager

Thermo Fisher Scientific

Lacey Harbour is a Molecular Biologist turned Regulatory, Quality, and Clinical Strategist, experienced in bringing diverse medical devices to market. She specializes in validating machine learning algorithms in healthcare, focusing on safety and effectiveness. Through AFDO/RAPS involvement, she advocates for state-of-the-art medical care while ensuring patient safety and global accessibility.

Cindy

Ipach

President & CEO

Compliance Insight

Cynthia Ipach, President and CEO of Compliance Insight, Inc., founded the company in 2000. With over 30 years in pharmaceuticals, medical devices, dietary supplements, and biologics, she has guided hundreds of companies through FDA compliance. Starting in Analytical Research and Development, she moved to Regulatory Affairs and Quality Assurance before serving as Director of Scientific Affairs at Pharmacia. Recently, she co-leads AFDO/RAPS’s AI in Operations Group, developing AI maturity models for healthcare.

Matthew

Schmucki

Associate Director of Automation Engineering

Vertex Pharmaceuticals

Matt serves as Associate Director for data automation and engineering at Vertex Pharmaceuticals, managing manufacturing data analytics across internal and external partnerships. With 15+ years supporting various pharmaceutical products, he brings expertise from startups to major pharma companies. He holds a mechanical engineering degree from University of Cincinnati and Doctorate in Business Intelligence, and guest lectures at Xavier University’s Quality Science programs.

Sundar

Selvatharasu

Chief Compliance Officer – GxP Operations

Sierra Labs

Sundar Selvatharasu serves as an FDA compliance expert, providing strategic solutions for emerging technologies across biopharma, medical devices, and healthcare industries. He collaborates with regulatory officials globally, leads multinational audits, and regularly speaks on security, data integrity, and quality systems. He contributes to industry publications and training on technology adoption compliance.

Join the AIO Work Team

You have an opportunity to work with your industry and regulator peers to develop solutions that will advance the predictive capabilities of the industry.

The AIO Team operates virtually from September through August each year, and is led by a structured leadership team toward predefined goals and deliverables.

The team leaders present the outcome of the work during the AI Summit that occurs each August. You will be recognized for your contributions at the Summit and in team publications.

Meeting frequency and duration is based upon what is needed to support progress against the deliverables. Team members volunteer to work on specific aspects based on their expertise.

If you are interested in joining the AIO Working Team, please note:

  • There is an annual participation fee of $100* per team to support Healthcare Products Collaborative’s ability to lead these initiatives.
  • It is expected that you participate in the standing meetings (schedule is determined by each team).
  • Plan on a time commitment of 5 hours per month, but this may vary.

The AFDO/RAPS Healthcare Products Collaborative is a joint venture established in 2022 between the Association of Food and Drug Officials and the Regulatory Affairs Professionals Society. Learn more.

Newsletter

Stay in the know about upcoming events and breaking news from the collaborative.

Subscribe

ContACT Us

Have questions about our events, registration, CEUs, sponsorship, or something else?

Get in touch

© 2024 AFDO/RAPS Healthcare Products Collaborative